Evidence map›Paper›PMID 31389267›Full record

ArticleDrug delivery2019

Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model.

Feng Zhang, Ke Liu, Zheng Pan, Mengdan Cao, Dengming Zhou, Hairong Liu, Yuting Huang, Xuanchu Duan

Open access · goldAbstract read
In one paragraph

Article in Drug delivery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Quercetin modified electrospun PHBV fibrous scaffold enhances cartilage regeneration.Journal of materials science. Materials in medicine · 2021
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Feng Zhanga Department of Ophthalmology, The Second Xiangya Hospital, Central South University , Changsha , Hunan Province , China.
Ke Liua Department of Ophthalmology, The Second Xiangya Hospital, Central South University , Changsha , Hunan Province , China.
Zheng Pana Department of Ophthalmology, The Second Xiangya Hospital, Central South University , Changsha , Hunan Province , China.
Mengdan Caoa Department of Ophthalmology, The Second Xiangya Hospital, Central South University , Changsha , Hunan Province , China.
Dengming Zhoua Department of Ophthalmology, The Second Xiangya Hospital, Central South University , Changsha , Hunan Province , China.
Hairong Liub College of Materials Science and Engineering, Hunan University , Changsha , Hunan , China.
Yuting Huangb College of Materials Science and Engineering, Hunan University , Changsha , Hunan , China.
Xuanchu Duana Department of Ophthalmology, The Second Xiangya Hospital, Central South University , Changsha , Hunan Province , China.
Second Xiangya Hospital of Central South University · CNHunan University · CNHe Eye Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study is to investigate the effects and toxicities of poly(3-hydroxybutyric acid-

Indexed as

AnimalsCicatrixConjunctivaCorneaDisease Models, AnimalDrug Delivery SystemsFibrosisFiltering SurgeryGlaucomaIntraocular PressurePolyestersPolyhydroxybutyratesRabbitsRosiglitazoneWound Healingpoly(3-hydroxybutyrate)-co-(3-hydroxyvalerate)PolyestersPolyhydroxybutyratesRosiglitazoneDrug delivery systemglaucoma filtration surgeryPHBVrosiglitazone

Identifiers

PMID31389267
PMCPMC6713170
OpenAlexW2965549941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.